Welcome to the iPill Dispenser

Patients receive prescription opioid medications in unsecured bottles. 

What prevents them from abusing their prescriptions?

ABSOLUTELY NOTHING.

The iPill was one of eight company chosen by the FDA in the FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder

https://www.fda.gov/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cdrh/cdrhinnovation/ucm609082.htm#background 

In the hospital, opioids are stored under lock and key and dispensed by trained healthcare providers.  Patients who receive opioids at the hospital are closely monitored for side effects. There is no similar regulation or monitoring at a patient's home. Patient safety should be equal from the hospital to the home. 

The iPill App and iPill Dispenser provides a solution: 

• to enforce prescription adherence to prevent simple overconsumption
• to prevent diversion of opioids by using fast 4-point biometric authentication
• to provide a safe tamper-resistant storage solution
• to provide blockchain electronic medical record connectivity for physician remote access
• to provide non-opioid cognitive behavior interventions such as social networks, music, games, family, and AR/VR entertainment 
• to detect respiratory depression and alert life saving rescuers

The iPill's safe storage solution to prevent diversion will be more cost effective than extended-release, abuse deterrent opioids that cost hundreds to thousands of dollars per month. An active control system that prevents opioid overconsumption prevents a $12,000 emergency room visit, a $28,000 hospital stay or a $128,000 inpatient rehabilitation.

A prototype has been built.  

If you are interested, please contact me.